Bag 1 acts as a co-chaperone for Hsp70/Hsc70. We report here that stable over-expression of Bag1 in immortalized neuronal CSM14.1 cells prevents death following serum deprivation. Bag1 over-expression slowed the proliferative rate of CSM14.1 cells, resulted in increased levels of phospo-MAP kinases and accelerated neuronal differentiation. Immunocytochemistry revealed mostly nuclear localization of Bag1 protein in these cells. However, during differentiation in vitro, Bag1 protein shifted from predominantly nuclear to mostly cytosolic in CSM14.1 cells. To explore in vivo parallels of these findings, we investigated Bag1 expression in the developing mouse nervous system using immunohistochemical methods. Early in brain development, Bag1 was found in nuclei of neuronal precursor cells, whereas cytosolic Bag1 staining was observed mainly after completion of neuronal precursor migration and differentiation. Taken together, these findings raise the possibility that the Bag1 protein is expressed early in neurogenesis in vivo and is capable of modulating neuronal cell survival and differentiation at least in part from a nuclear location.
Introduction
Bag1 (Bcl-2-associated athanogene-1) is the first identified member of a family of Hsp70-binding proteins containing a conserved C-terminal region termed the`Bag domain'. 1 ± 3 The Bag domain binds tightly to the ATPase domain of the Hsp70 family of molecular chaperones and regulates their activity. Diversity in the N-terminal regions of BAG-family proteins permits their association with specific target proteins or targeting to subcellular locations.
Bag1 was identified by virtue of its ability to bind and collaborate with Bcl-2 in suppressing cell death. 1 Since then, multiple functions have been reported for Bag1, including interactions with the serine/threonine-specific protein kinase Raf, some tyrosine kinase growth factor receptors, and several steroid hormone receptors. 4 ± 6 At the cellular level, over-expression of Bag1 can result in various phenotypes, including enhanced tumor cell proliferation, promotion of cell motility and metastasis, and increased resistance to apoptosis. 1,2,5,7 ± 14 Programmed cell death or apoptosis is a crucial feature ensuring proper development and differentiation of the nervous system. Moreover, in response to many injuries, such as stroke, neurodegenerative disease and trauma, differentiated neurons are known to induce the expression of stress proteins, including heat shock proteins. 15, 16 Bag1 is expressed in the developing and mature mammalian nervous system. 17, 18 However, detailed information about the expression and function of Bag1 during neuronal development, differentiation and death is currently limited. For example, Bag1 has been shown to prevent apoptosis in PC12 cells in vitro when over-expressed together with Bcl-2. 9 A similar synergistic effect of Bag1 and Bcl-2 has been demonstrated in an in vivo model of photoreceptor cell death involving transgenic mice expressing these genes under the control of the rod opsin promoter. 19 Furthermore, loss of Bag1 immunoreactivity in the rat brain after transient middle cerebral artery occlusion 20 and in olfactory neurons following synaptic target ablation 21 suggests a potential role for Bag1 in suppression of neuronal death.
Two isoforms of the mouse Bag1 protein resulting from alternative translation initiation codon selection within a single mRNA have been reported. 22 In contrast to the human Bag1 protein, little is known about the intracellular location of these two proteins. In the present study, we demonstrate that when stably over-expressed in the immortalized neuronal cell line CSM14.1, the short p29 form of mouse Bag1 resides predominantly in the nucleus. Bag1 not only prevents neuronal death but also promoted neuronal differentiation in vitro in these cells. During differentiation, Bag1 protein accumulated in the cytosol of CSM14.1 cells, becoming absent from the nucleus. An analysis of Bag1 expression during neuronal development in the mouse in vivo revealed similar patterns of Bag1 protein expression and intracellular location when compared to neuronal differentiation in vitro. The findings suggest that Bag1 is capable of modulating neuronal death and differentiation from a nuclear location.
Results
Over-expression of mBag1 in neuronal CSM14.1 cells tagged mouse p29 Bag1 driven by the neuron-specific enolase (NSE) promoter ( Figure 1A) . In a co-transfection, we introduced pBabePURO containing a puromycin resistance gene as selection marker. The plasmid containing a NSE-driven luciferase gene served as control vector. Prior to and after selection of single cell clones, gene expression was checked by immunoblot analysis employing antibodies against Bag1 (Bur 1680 and 1735) and Flag. Flag-mBag1, which migrates in gels at a slightly higher molecular weight than endogenous Bag1, was strongly expressed ( Figure 1B) . Out of 30 clones tested, 12 were positive for over-expression of Bag1. Two clones (#15 and 20) were chosen for further analysis.
Localization of Bag1 protein in CSM14.1 cells
To explore the intracellular location of Bag1 in CSM14.1 neuronal cells, we performed immunofluorescence microscopy analysis of our stably-transfected cells, employing two antibodies raised against different epitopes of Bag1. Compared to the levels of endogenous Bag1 expression in CSM14.1 cells, we observed a striking increase in nuclear immunofluorescence in cells over-expressing Bag1 ( Figure  1C ). In contrast, staining with preimmune serum and rabbit IgG produced no immunofluorescence, demonstrating the specificity of these results (not shown).
To verify our findings, we applied an antibody against Flag. As shown in Figure 1C , the tagged version of Bag1 was detected mainly in the nucleus of Bag1-transfected cells. In contrast, no immunofluorescence was observed in control-transfected CSM14.1 cells using anti-Flag antibody ( Figure 1C ).
Bag1 inhibits cell death after serum starvation
Serum starvation induces death of CSM14.1 cells maintained at 398C. 23 After 2 days without serum, approximately 40% of wild-type cells were dead ( Figure 2 ). This death can be largely attributed to apoptosis, since cells displayed fragmented nuclei (as visualized by DAPI staining) and could be protected by treatment with the broad-spectrum caspase inhibitor z-VAD-fmk (data not shown). As shown in Figure 2 , stable Bag1 over-expression significantly prevented cell death measured at 24 and 48 h after serum deprivation (P50.01), while transfection with control vector (CSMIuc) did not. Both of the stably-transfected clones tested, Bag15 and Bag20, which express the transgene at comparable levels (see insert in Figure 2 ), displayed substantially reduced cell death rates (~50%) when compared to control-transfected cells.
Since cell death prevention by stable over-expression of Bcl-2 in CSM14.1 cells has been reported previously, 23 we also compared Bag1 transfectants to Bcl-2 over-expressing CSM14.1 cells. As shown, Bcl-2 proved to be more effective than Bag1, abolishing cell death following serum deprivation almost completely ( Figure 2 ).
Bag1 induces differentiation of CSM14.1 cells
We observed changes in morphology of Bag1 overexpressing cells even when cultured at the`permissive' temperature of 328C. In contrast to the small and round shape of wild-type cells, Bag1 over-expressing cells look larger and display a more polarized shape (not shown, compare Figure 1C ).
Since differentiation of CSM14.1 cells is known to occur after switching temperature to 398C, 23 we suspected that Bag1 might promote differentiation of these cells. Since neuronal differentiation is associated with a cessation of cell proliferation, we first assessed the doubling time of control and Bag1 over-expressing CSM14.1 cells. We found a highly significant difference in the generation times of the respective cell lines at 328C (P50.01). Cells overexpressing Bag1 were less proliferative, with an average generation time of 42 h, whereas wild-type CSM14.1 and empty vector transfected cells doubled on average every 25 h ( Figure 3A ). To further explore the effects of Bag1 on differentiation of CSM14.1 cells, experiments were performed in which CSM14.1 cells were switched to non-permissive temperature of 398C (where the SV40 large T-antigen is inactive) and cell morphology was compared at various times thereafter. Figure 3B , for example, contrasts the morphology of wild-type and Bag1 over-expressing cells at two different times after switching to 398C. After 8 days at 398C, most wild-type and control-transfected CSM14.1 cells had an enlarged cell soma containing a big nucleus. However, few of these cells had started to extend axon-like processes. In contrast, in cultures of Bag1 over-expressing cells, almost all of the cells were much smaller in size and assumed a more polarized shape. Virtually all of these cells had grown processes, which often aligned, forming bundles. Measurement of the length of these processes after 8 days at non-permissive temperature revealed that axon-like structures in Bag1 over-expressing cells had grown almost three times longer than processes in wildtype cells (P50.01; Figure 3C ). After extended periods at 398C, the morphological differences became even more pronounced. After 21 days at non-permissive temperature, Bag1 over-expressing cells were characterized by striking arborization of processes and formation of dense nests of axon-like connections between cells. In contrast, cells in cultures of wild-type or control-transfected cells had a less differentiated appearance, with residual large cells and far fewer cellular processes ( Figure 3B ).
To correlate these differences in morphological changes with markers of the neuronal phenotype, we investigated the expression of neuronal differentiation-associated proteins in these cell lines. After extended time at nonpermissive temperature, weak Neurofilament-200 staining could be detected in cultures of either control-or Bag1 over-expressing CSM14.1 cells (data not shown). In contrast, positive staining for NeuN antigen (a marker of post-mitotic neuronal nuclei) was observed in most Bag-1 over-expressing cells by day 21 at 398C, while NeuN staining was very weak or completely absent in control CSM14.1 cells ( Figure 3D ).
Interestingly, during neuronal differentiation at nonpermissive temperature, there was a loss of nuclear Bag1 expression. Figure 3E illustrates the localization of Bag1 in stably transfected CSM14.1 cells after 28 days at nonpermissive temperature using polyclonal antiserum against Bag1 (Bur 1680). In contrast to the mainly nuclear location of flag-mBag1 at permissive temperature (compare Figure  1C ), most Bag1-transfectants over-expressing cells display an exclusively cytosolic location of Bag1, as revealed by double-labeling with DAPI ( Figure 3E ). As before, staining with preimmune serum and control rabbit IgG served as negative controls (not shown).
Bag1 over-expression induces MAPK-pathway
Given the accelerated differentiation of Bag1 over-expressing cells after switch to non-permissive temperature we hypothesized that the activation of MAP kinases, known to be important players in neuronal differentiation, contributes to this phenotype. As shown in Figure 4 , Bag1 over-expressing cells showed increased levels of phospho-Erk1/2 at permissive temperature of 328C when compared to wild-type cells. These high levels of Erk1 and 2 phosphorylation were maintained after switch to 398C. In wild-type cells, only a modest increase in Erk-phosophorylation could be detected following temperature switch, while the expression of nonphosphorylated Erks did not change significantly in both cell types over time. Interestingly, the temperature switch induced increased levels of Hsp70 with similar kinetics in both wildtype and Bag1 over-expressing cells (Figure 4 ).
Bag1 expression during development of the mouse nervous system
Bag1 expression in the developing mouse nervous system was studied using immunohistochemical methods. At the onset of neurulation (E7.5 ± 8), neural folds in the cephalic region contained only trace levels of Bag1 immunostaining. A single layer of pseudostratified columnar epithelium, constituting the neuroepithelium of the primitive neural tube, exhibited barely detectable cytosolic Bag1 staining ( Figure  5A ). With the formation of the three primary brain vesicles at E8.5 ± 9.5, Bag1 nuclear staining appeared and was located predominantly in the differentiating neuroblasts of the rhombencephalon and mesencephalon, and at lower levels At a later stage of neural differentiation (E10 ± 11), when the division of the primitive neural tube into three concentric layers occurs, neuroblasts in proliferative, periventricular matrix zone were consistently negative for Bag1. An obvious gradient of Bag1 expression appeared at this stage, associated with differentiation of the peripherally migrating progeny of ventricular neuroblasts to the intermediate mantle layer. The cells with early features of neuronal differentiation in the mantle layer, which gives rise to the gray matter of the central nervous system, demonstrated strong nuclear Bag1 immunostaining ( Figure  5E ).
At E12, when the various regions of the brain are more clearly defined, roughly half of the migrating postmitotic neurons evidenced not only intense nuclear staining but also increasing cytoplasmic Bag1 immunoreactivity ( Figure  5F ) in the hypothalamus, thalamus, and corpus striatum (the major derivatives of the diencephalon). At this time, a significant increase of Bag1 immunoreactivity also became apparent in the developing peripheral nervous system. Strong nuclear labeling was evident in the differentiating sensory neurons of the dorsal root ganglia ( Figure 5G) , and in the segmental ganglia along sympathetic trunks. The cranial ganglia, such as the facial (VII), acoustic (VIII), and the glossopharyngeal (IX) ganglion complexes revealed a similar distribution pattern (data not shown).
By E13 ± 14 in the central nervous system of developing embryos, differentiating neuroblasts in the neopallial cortex (which is formed as cells from the mantle layer of the telencephalic vesicles migrate into the overlying marginal zone to constitute in due course the outer gray layer of the cerebral hemispheres) contained moderate levels of cytosolic Bag1, whereas the intensity of the nuclear signal had greatly declined. In the forming hippocampal plate, nuclear Bag1 immunoreactivity remained only in the rare residual migrating neuroblasts throughout most of the thickness of the plate (data not shown). This trend toward diminishing nuclear and increasing cytosolic Bag1 immunostaining in more differentiated neurons continued throughout the remaining nervous system development in multiple regions of the brain and peripheral nervous system, including the spinal cord ( Figure 5H,J) , sympathetic trunk ganglia ( Figure 5 ), olfactory bulb, pyramidal neurons of the CA3-CA4 sector of the hippocampus ( Figure 5K,L) , diencephalons, mesencephalon and rhombencaphalon as well as the retina (Figure 5M,N) . Control stainings performed with preimmune serum or using anti-Bag1 antibody that had been pre-adsorbed with Bag1 protein or peptide antigen confirmed the specificity of these results ( Figure 5O, not shown) .
During the later fetal life and into adulthood, selected types of neurons retained Bag1 expression, which was predominantly localized to the cytosol.
Discussion
Bag1 is an anti-apoptotic protein capable of binding to Bcl-2. Recently, binding of Bag1 to a variety of other intracellular proteins linking cell signaling, cell death and cellular stress responses has been shown. 3 In the present report, we suggest a new function of Bag1 as a regulator of neuronal differentiation in vitro and as a marker of neuronal differentiation in vivo in the developing mouse nervous system.
For our in vitro studies, we used the neuronal cell line CSM14.1 which originated from rat nigral neurons immortalized by expression of temperature-sensitive SV40 large T antigen. These cells show a high proliferative rate at permissive temperature, while inactivation of large T antigen at non-permissive temperature induces neuronal differentiation. 23 Over-expression of Bcl-2 in these cells has been shown to protect them from a variety of death stimuli, including serum starvation. 23 To explore a potential role for Bag1 in the control of neuronal death, we stably over-expressed mouse Bag1 in CSM14.1 cells under the control of the neuron-specific NSE promoter. 24 Over-expression of Bag1 significantly reduced apoptotic cell death induced by serum deprivation in cultures of CSM14.1 cells. Similarly, Bag1 has been shown to reduce cell death following growth factor withdrawal in 3T3 fibroblasts, Ba/F hematopoietic cells and PC12 neural cells. 1, 7, 9 In contrast, Roth and co-workers 25 reported synergistic effects of Bag1 and Bcl-2, but no cyto-protective effects of Bag1 alone in a model of glioma cell death following serum starvation.
Besides cyto-protective effects, Bag1 over-expression in CSM14.1 cells promoted neuronal differentiation. Previously, the protein kinase Raf-1 has been shown to play an important role in neuronal differentiation. 26 Bag1 interacts with Raf-1 and enhances its activity. 6, 27 The regions in Bag1 required for Raf-1-binding are overlapping with but distinct from those involved in Hsp70 binding. 6, 27 Raf kinase is a proximal element of the Ras-Raf-mitogenactivated protein kinases (MAPK) cascade. This pathway is a central effector of cellular differentiation during development 28 and seems also to subserve memory and synaptic plasticity in the post-mitotic, mature nervous system. 29 Consequently, Bag1 over-expressing neuronal cells displayed markedly increased levels of phospho-Erk1/2, the downstream kinases in the MAPK cascade. Interestingly, Figure 4 Bag1 over-expression activates MAPK pathway. Lysates of wildtype (WT) and Bag1 over-expressing (Bag1) cells at different time-points after switch to 398C were subjected to SDS ± PAGE and analyzed by immunoblot incubating the same membrane sequentially with phospho-Erk1/2, Hsp70, Bag1 and Erk1/2 antibodies. Bag1 over-expressing cells displayed markedly increased levels of phospho-Erk1/2 Figure 5 Bag1 expression in the developing nervous system of the mouse. Representative photomicrographs are shown for analysis of Bag1 expression in the mouse nervous system. Antibody detection was achieved using a DAB-based chromogenic method (brown) and nuclei were counterstained with hematoxylin. All results presented in this figure were obtained using a rabbit polyclonal antibody raised against a synthetic peptide (BUR1735), but similar results were observed using alternative antibodies (BUR1680 and 1702, not shown). increased levels of active MAP kinases were already present at permissive temperature and associated with altered morphology of the cells. However, expression of neuronal differentiation markers could only be observed after switch to non-permissive temperature of 398C, where the large T antigen becomes inactive in these cells. It is tempting to speculate therefore that the signal for diffentiation provided by MAPK activation was insufficient to overcome the proliferative stimulus of active SV40 large T antigen. However, after inactivating T antigen by switching to 398C, increased levels of phosphorylated MAPKs in Bag1-expressing cells triggered differentiation into postmitotic neurons.
We observed a significantly increased doubling time of Bag1-expressing CSM14.1 cells even at permissive temperature where large T antigen is active. Similarly, Bag1 was reported to slow glioma cell growth both in control and under serum-deprived conditions. 25 Recent findings support a role for Bag1 in cell growth regulation. 13, 27 Over-expression of Bag1, for example, can promote factor-independent growth of Interleukin 3-dependent lymphoid precursor cells 7 and interfere with p53-mediated cell cycle arrest in epithelial tumor cell lines. 13 In this regard, it has been shown that Bag1 binds to the human homologue of Drosophila seven in absentia (Siah), 13 a p53-inducible gene. 30 Interestingly, in a transient transfection assay of the human kidney cell line 293T, overexpressed Siah-1 recruited Bag1 exclusively into the nucleus. 13 Our data however argue that effects of Bag1 on cell proliferation are likely to be influenced by cellular background or lineage, given that Bag1 suppressed rather than stimulated growth of CSM14.1 neuronal cells. In line with this, Bag1 also failed to overcome p53-induced growth arrest in two human glioma cell lines. 25, 31 The reasons for differences in the effects of Bag1 protein over-expression on proliferation of neural versus epithelial or hematopoietic lineage cells are unknown, but a possible clue may come from contrasting the intracellular locations of this protein in cells. In the mouse, two isoforms of Bag1 have been described, with the shorter one studied here representing the more abundant gene product by far. 22 The intracellular location of this Bag1 protein isoform may vary depending on cell background, environment and stage of differentiation, 22, 32 In CSM14.1 cells, we detected Bag1 transgene expression predominantly in the nucleus of undifferentiated CSM14.1 cells. In contrast, p29 Bag1 is reportedly found predominantly in the cytosol of epithelial and hematopoietic cells. 7, 22 After shifting CSM14.1 cells to nonpermissive temperature to allow differentiation, Bag1 protein accumulated in the cytosol over time, becoming absent from the nucleus. Accordingly, Bag1 presumably interacts with different molecular targets and exerts different effects depending on its intracellular location and cell type.
Interestingly, in the developing mouse nervous system, we found a similar situation with respect to Bag1 expression patterns, suggesting that Bag1 may modulate neuronal differentiation from a nuclear location. During neuronal differentiation in the mouse brain, Bag1 expression was highest in differentiating neuroblasts. Bag1 immunoreactivity was restricted to the nuclei of these cells, whereas low levels of cytosolic Bag1 were detected later in development in mature neurons. This shift of Bag1 expression from predominantly nuclear to mostly cytosolic, in parallel with neuronal maturation, was observed in all parts of the nervous system. In summary, our results suggest a new function for Bag1 as a marker and regulator of neuronal differentiation. Future studies investigating the association of Bag1 expression with neuronal differentiation in vivo, particularly the generation of Bag1 transgenic and knock-out mice, should yield additional insights which might eventually be exploited for neuronal preservation or replacements after stroke, neurodegeneration, or other diseases.
Materials and Methods

Plasmid constructions
A plasmid was constructed for expression of flag-mouseBag1 (mBag1) under control of the neuron-specific enolase (NSE) promoter. First the 1.8 kb 5'-fragment of the rat NSE-promoter, 24 kindly provided by G Sutcliffe, was subcloned into pBSKII using the EcoRI and HindIII restriction sites. In a second step, this plasmid was digested with BamHI and HindIII. The resulting NSE-promoter containing fragment was used to replace the HSV-TK promoter in pRL-TK (Promega) between the BglII and HindIII sites. The resulting construct containing a luciferase gene under the control of the NSE promoter served as control vector. Subsequently, flag-mBag1 was inserted at the NheI and NotI sites from pCI-flag-mBag1. 1 
Stable transfections
The rat nigro-striatal cell line CSM14.1, immortalized by introduction of the temperature sensitive SV40 large T antigen, and a Bcl-2 transfectant CSM 14.1-Bcl-2 23 were kindly provided by Dale Bredesen. Cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FBS (fetal bovine serum), 1 mM L-glutamine, 100 U/ml penicillin, and 100 mg/ml streptomycin sulfate either in 328C at permissive or 398C at non-permissive temperature. 23 For stable transfection, 50 ± 70% confluent CSM cells in 6-well plates were incubated with Gene Porter II according to the supplier's protocol (Gene Therapy Systems) in serum-free medium containing 3 mg of plasmid DNA representing a 5 : 1 ratio of specific plasmid : puromycin-resistance plasmid (pBabe-puro). After 3 h at 378C, serum-containing medium was added and the cells were incubated overnight. Finally, the transfection agent was replaced by 10% serum-containing medium and the cells were transferred to 328C. Selection with 4 mg puromycin in complete medium was started the next day. After 5 days, 0.5 cells per well were seeded in 96-well plates with selection medium, and 3 to 4 weeks later wells containing single clones were identified by light microscopy and the cells transferred to larger plates for expansion and further processing.
Cell death, cell division assays and measurement of neurite outgrowth Cell death was induced by serum deprivation as published previously. 23 10 5 cells were plated in 6-well plates and maintained in 398C. Prior to serum deprivation, cells were washed three times in serum-free medium. Cell death was assessed by Trypan Blue exclusion after 24 h, 2, 3, and 4 days in serum starvation. Experiments were repeated six times. Doubling times were determined during logarithmic growth in 24-well plates. 10 4 cells were plated and daily cell counts were performed by Trypan Blue exclusion assay for 1 week.
The length of outgrowing neurites was assessed on day 8 at 398C in three independent experiments on randomly picked cells using ImagePro-Plus software.
Statistics were performed using two-tailed Student's t-test.
Antibodies
Polyclonal antisera for Bag1 were generated in rabbits using synthetic peptides or GST-fusion protein immunogens. A peptide (NH2-CNERYDLLVTPQQNSEPVVQD-amide) corresponding to residues 26 ± 45 of the mouse Bag1 protein, was synthesized with an Nterminal cysteine appended to permit conjugation to maleimideactivated carrier proteins KLH and OVA (Pierce, Inc.), as described previously. 33 This peptide conjugate was used to generate a polyclonal antiserum (#1735) in rabbits. 22 An additional anti-Bag1 serum (#1680) was generated in rabbit using a GST-mouse Bag1 (8 ± 219) fusion protein. 1 The generation and characterization of a rabbit anti-mouse Bag1 antiserum targeted against amino acids 204 ± 219 (#1702) have been described. 1 
Immunoblot assays and immuno¯uorescence
Cell lysates were prepared at different times after switching cells to non-permissive temperature using RIPA buffer as described. 34 Proteins (20 mg per lane) were resolved by SDS ± PAGE and transferred onto nitrocellulose membranes. After blocking with 5% skim milk, 2% bovine serum albumin (BSA) in TBST (10 mM Tris [pH 7.5]; 142 mM NaCl; 0.1% Tween-20) at room temperature for 2 h, blots were incubated in the same solution with various primary antibodies including polyclonal antisera against Bag1 (Bur 1735 and Bur 1680; 1 : 1000; see above), phospho-Erk1/2 and Erk1/2 (Cell Signaling; 1 : 1000), as well as monoclonal antibodies against Flag (Sigma M2 or M5; 3 mg/ml) and Hsp70 (ABT; 1 : 5000), followed by horseradish peroxidase-conjugated anti-mouse or anti-rabbit IgG (Biorad) secondary antibodies. Bound antibodies were visualized using an enhanced chemiluminscence (ECL) detection system (Amersham).
For immunofluorescence, wild-type cells and those stably transfected with either empty vector or flag-mBag1 were trypsinized and seeded into chamber slides. Cells were either maintained in 32 or 398C until further processing. After various lengths of time, cells were washed in PBS and fixed in PBS containing 4% paraformaldehyde for 5 min at room temperature, followed by several washing steps in PBS. Permeabilization was performed in 0.3% Triton X-100/PBS for 5 min with subsequent preblocking in PBS containing 2% normal goat serum. Cells were incubated in blocking solution containing the following primary antibodies: Bur 1680 and 1735 (1 : 100), anti-Tubulin (1 : 2000), anti-Flag M5 (1 : 250), NeuN (Sigma, 1 : 50). After washing three times in PBS and incubation with FITC-conjugated secondary anti-mouse or anti-rabbit antibody (Dako, 1:50) for 2 h at room temperature, slides were covered with Vectashield mounting medium with or without 1.5 mg/ml 4,6-diamidino-2-phenylindole (DAPI) (Vector Laboratories) and sealed with Cytoseal 60 mounting medium (Stephens Scientific).
Immunohistochemical analysis of mouse embryos
The timing and distribution of Bag1 protein expression in the developing nervous system were assessed in paraffin sections derived from embryos and postnatal mice of the NMRI or FVB strains.
All procedures were approved by the institutional animal care committee. Prenatal development was studied on a closely spaced series of mouse embryos at daily intervals from 6 days or gestation (E6) to postnatal day 4 (P4). Twenty-five mice were studied at weekly intervals after that time until adulthood. Mice were mated overnight, and the morning the vaginal plug appeared was designated as embryonal day 0.5 (E0.5). The day of birth was termed as postnatal day zero (PO). All embryos were taken from mice which had been killed by over-dose of carbon dioxide. At E4 ± 9, the uterus was excised and fixed with the embryos in situ. For the later embryos, each embryo was dissected from the uterus, freed from the extra-embryonic membranes and immediately placed in the fixatives, either Bouin's fixative, or zinc-buffered formalin (Z-fix; Anatech LTD, Battle Creek, MI, USA). Immersion time varied from 2 days for early stages to 5 ± 7 days for fetal and postnatal specimens. Altogether, tissue specimens from 58 embryos and 29 mice after birth have been paraffin-embedded according to routine procedures.
Dewaxed tissue sections were exposed to polyclonal antibodies and confirmed to be specific for Bag1. The sections were immunostained using a diaminobenzidine (DAB)-based detection method as described in detail, employing either an avidin-biotin complex reagent (Vector Laboratories) or the Envision-Plus-Horse Radish Peroxidase (HRP) system (DAKO) using an automated immunostainer (Dako Universal Staining System. 33, 35 The dilutions of antisera typically employed were 1 : 3500 (v/v) for #1735, 1 : 5000 for #1680, and 1 : 2500 for #1702.
To verify specificity of the results, the immunostaining procedure was performed in parallel using preimmune serum or anti-Bag1 antiserum preadsorbed with 5 ± 10 mg/ml of synthetic peptide immunogen.
